Personalised Medicine and Resource Allocation Conference

Mark Connolly

 

Unit of PharmacoEpidemiology & PharmacoEconomics, Department of Pharmacy, University of Groningen, The Netherlands.
Global Market Access Solutions (GMAS), St-Prex, Switzerland.

 

Mark Connolly

Opportunities & Challenges in diagnostic embryo Selection during Assisted Reproduction: Practical & Conceptual Issues

As with other areas of personalised medicine, diagnostic testing costs are of concern, although improved embryo selection leads to the reduction in future costs and the need for future interventions. This presentation describes a recent cost-effectiveness analysis applied to a theoretical embryo diagnostic procedure and its influence on the cost per live birth. This case study is used to illustrate unique features of cost-effectiveness analysis of personalised medicine in reproductive healthcare and influence on resource allocation.